Controversies in the treatment of hypercholesterolemia in the elderly: who should be treated and how?
High levels of low-density lipoprotein cholesterol may contribute to the development of coronary heart disease in the absence of other risk factors. This paper reviews major cholesterol prevention trials since 1994 concerning possible beneficial results of lowering cholesterol in persons over 65 years of age.
Miura
D S
DS
Albert Einstein College of Medicine, New York, NY, USA.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000191:economics; D008875:Middle Aged; D012307:Risk Factors